Clinical trial
Comparison of Standard and High Dose Irinotecan Based on UGT1A1 Genotype, 5-fluorouracil, and Leucovorin (FOLFIRI) for First-line Treatment of Locally Advanced Colon Cancer: a Prospective Phase II Clinical Study
NCT01826396 is registered in ClinicalTrials.gov with Colorectal Cancer Institute of the Heilongjiang Academy of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Standard and High Dose Irinotecan Based on UGT1A1 Genotype, 5-fluorouracil, and Leucovorin (FOLFIRI) for First-line Treatment of Locally Advanced Colon Cancer: a Prospective Phase II Clinical Study
- Lead sponsor
- Colorectal Cancer Institute of the Heilongjiang Academy of Medical Sciences
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- April 30, 2013
- Completion date
- December 31, 2014
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.